UC Davis research pivots to take on COVID-19
UC Davis research pivots to take on COVID-19
The COVID-19 pandemic is a health challenge of global proportions. UC Davis research teams are racing to find treatments for the deadly disease. The university, with its unique range of both human and veterinary medicine capabilities, now has 38 novel coronavirus studies underway at its campuses in Davis and Sacramento. This critically important work includes efforts to help develop a vaccine that would prevent infection by the SARS-CoV-2 virus and reduce its devastating effects.
With the rising number of COVID-19 cases and deaths, there is no greater need in the world than to identify safe and effective therapies to prevent novel coronavirus infections and lessen the severity of COVID-19 illnesses.
UC Davis Health already has 14 clinical trials underway, including studies of potential vaccines and medication treatments, as well research into the extraordinary impacts that the pandemic has had on the lives of people and specific groups such underserved and low-income communities.